| Literature DB >> 26302442 |
Chisato Oba1, Masashi Morifuji1, Satomi Ichikawa1, Kyoko Ito1, Keiko Kawahata1, Taketo Yamaji1, Yukio Asami1, Hiroyuki Itou1, Tatsuya Sugawara2.
Abstract
Exposure to ultraviolet-B (UV-B) irradiation causes skin barrier defects. Based on earlier findings that milk phospholipids containing high amounts of sphingomyelin (SM) improved the water content of the stratum corneum (SC) in normal mice, here we investigated the effects of dietary milk SM on skin barrier defects induced by a single dose of UV-B irradiation in hairless mice. Nine week old hairless mice were orally administrated SM (146 mg/kg BW/day) for a total of ten days. After seven days of SM administration, the dorsal skin was exposed to a single dose of UV-B (20 mJ/cm2). Administration of SM significantly suppressed an increase in transepidermal water loss and a decrease in SC water content induced by UV-B irradiation. SM supplementation significantly maintained covalently-bound ω-hydroxy ceramide levels and down-regulated mRNA levels of acute inflammation-associated genes, including thymic stromal lymphopoietin, interleukin-1 beta, and interleukin-6. Furthermore, significantly higher levels of loricrin and transglutaminase-3 mRNA were observed in the SM group. Our study shows for the first time that dietary SM modulates epidermal structures, and can help prevent disruption of skin barrier function after UV-B irradiation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26302442 PMCID: PMC4547804 DOI: 10.1371/journal.pone.0136377
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Effect of sphingomyelin on TEWL and SC water content (B) after UV-B irradiation.
(A) Transepidermal water loss (TEWL); (B) Stratum corneum (SC) water content. The values are shown as mean ± SD (n = 8/group). *: P < 0.05 (vs. the control group). #: P < 0.05 (vs. day 0).
Fig 2Effect of sphingomyelin on levels of covalently-bound ω-hydroxy ceramide in the epidermis induced by UV-B irradiation.
Levels of ω-hydroxy tetratriacontenoic sphingoshine (d18:1-ω-hydroxy C34:1) are expressed as relative peak area per epidermal protein content. The values are shown as mean ± SD (n = 8/group). *: P < 0.05 (vs. the control group). #: P < 0.05 (vs. day 0).
Fig 3Effect of sphingomyelin on expression levels of TSLP (A), IL-1 beta (B) and IL-6 (C).
(A) Thymic stromal lymphopoietin (TSLP); (B) Interleukin-1 (IL-1) beta; (C) Interleukin-6 (IL-6). The mRNA levels are expressed as fold-change ± SD (SD of ΔCt) (n = 8/group). *: P < 0.05 (vs. the control group). #: P < 0.05 (vs. day 0).
Fig 4Effect of sphingomyelin on Loricrin (A) and TGase-3 (B) mRNA expression.
(A) Loricrin; (B) Transglutaminase-3 (TGase-3). The mRNA levels are expressed as fold-change ± SD (SD of ΔCt) (n = 8/group). *: P < 0.05 (vs. the control group). #: P < 0.05 (vs. day 0).